To round off its full-service capabilities for clients, Boehringer Ingelheim is expanding its capacities and capabilities in fill & finish for biopharmaceuticals at their state-of-the-art facility in Biberach, Germany, with a new filling line. The new line is available as of today for contract filling of liquid and lyo vials from 0,5 ml- 100 ml. The expansion to a combination line for single and double chamber catridges will be up and running in Q4 2012. To meet the customers’ demand for clinical and commercial scale filling the batch sizes range from 6.000 – 110.000 ml for vials and 50.000 – 100.000 ml for carpoules.

The new line with isolator technique represents one further step in Boehringer Ingeheim's “one stop shop” for contract development and manufacturing of biopharmaceuticals. With this state of the art technology Boehringer Ingelheim offers further excellence and solutions in the contract manufacturing business to its customers in addition to the existing capacities for lyophilization, vial filling and filling in pre-filled syringes. Customers’ can rely on Boehringer Ingelheim either as a single supplier or they can also enter flexible at any step in the development.

“As a leader in its field, Boehringer Ingelheim has supported pharmaceutical companies in the successful launch of many biologic drugs” says Simon Sturge, corporate senior vice president Biopharmaceuticals. “I believe that this further expansion will benefit our customers by receiving high quality drug substance and drug product from one source with very convenient applications which bring an even higher benefit for the patients.”

The Boehringer Ingelheim group has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.